What did Johnson & Johnson pay clinicians in Massachusetts?

Where these numbers come from. Everything on this page is computed from CMS's public Open Payments (Sunshine Act) data for program year 2025. Federal law requires manufacturers and group purchasing organizations to report payments and transfers of value to physicians and other covered clinicians; CMS publishes the records each year. A reported payment is a disclosed financial relationship required by law. It is not evidence of anything improper, and it says nothing about whether a clinician uses, prefers, or prescribes any product. Totals are general payments only and exclude acquisition buyouts and debt forgiveness (one-time events, not working relationships). (Separately, $605 in buyout or debt-forgiveness rows was excluded from the totals here.) Research dollars are shown separately as associated funding: money tied to a study on which a clinician is named as recipient or principal investigator. It funds the study, not the person. Product rows count a payment toward every product named on it, across all payment types, so product rows do not add up to the total. Johnson & Johnson figures combine the 31 corporate entities that report under it, normalized so the whole company shows up as one. Clinicians whose federal enrollment record no longer lists a US practice state are not in state rollups. Prospect 811 organizes public data; it doesn't add to or alter it. Not affiliated with or endorsed by CMS. Full detail on the data page.